Meeting highlights from the Committee for Medicinal Products for Human Use
- Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 December 2023 | European Medicines Agency European Medicines Agency |
- The first CRISPR therapy approved in the U.S. will treat sickle cell disease Science News Magazine
- FDA approves cure for sickle cell disease, the first treatment to use gene-editing tool CRISPR NBC News
- Vertex-CRISPR’s Casgevy Gets Positive EMA Panel Opinion, Approval Decision in Q1 2024 BioSpace
- Biotech Stock Roundup: BLUE, CRSP & VRTX Get Gene Therapy Nod, ACAD Up on Patent News Yahoo Finance
Read More: Meeting highlights from the Committee for Medicinal Products for Human Use